U.S. PATENT AND TRADEMARK OFFICE (USPTO) SENDS NOTICE OF ALLOWANCE TO TIMBER PHARMACEUTICALS

Highlights

• Timber Pharmaceuticals Inc. has received a formal notice of allowance from the USPTO for its patent application covering its pharmaceutical isotretinoin composition

• Investigational therapy of Timber (TMB-001) is under the development for the treatment of moderate to severe subtypes of congenital ichthyosis (CI)

• If isotretinoin is formulated into a proprietary topical formulation, it....